Table 1.
Total and sex-specific prevalence statistics for clinical outcomes.
| Trait | Males ( N = 272) | Females ( N = 622) | p-value* | ||
|---|---|---|---|---|---|
| Prevalence | S.D. | Prevalence | S.D. | ||
| Norm Wt. | 17 | 0.02 | 14 | 0.01 | 0.161 |
| Over. Wt.BMI 26–29 | 31 | 0.03 | 29 | 0.02 | 0.335 |
| ObeseBMI > 30 | 53 | 0.03 | 57 | 0.02 | 0.156 |
| Norm.HbA1c <5.5 | 39 | 0.03 | 37 | 0.02 | 0.280 |
| Pre-DMHbA1C 5.5–6.5 | 29 | 0.03 | 31 | 0.02 | 0.280 |
| DMHbA1C >6.5 | 32 | 0.03 | 33 | 0.02 | 0.488 |
| HTN >140/90 | 46 | 0.03 | 36 | 0.02 | 0.002 |
| Cholesterol >200 | 7 | 0.02 | 6 | 0.01 | 0.187 |
| Triglycerides | 60 | 0.03 | 48 | 0.02 | 0.000 |
| >200 mg/DLLow HDL-C<40 mg/DL | 7 | 0.02 | 6 | 0.01 | 0.187 |
| Depression | 33 | 0.03 | 20 | 0.02 | <0.000 |
| PHQ9 >10 | 17 | 0.02 | 19 | 0.02 | 0.232 |
*
Prevalence differences were tested using a difference of proportion Z-statistic that is normally distributed for a one-tailed test. SD, Standard Deviation.